Synapse - Works

Results (2671)

A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer

Journal Article

Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Pre-surgical visceral adipose tissue may be a novel pre-surgical risk factor for acute kidney injury among clear cell renal cell cancer patients undergoing radical nephrectomy

Meeting Abstract

Sanchez, A.; Olson, L.; Knezevic, A.; Akin, O.; Scott, J. S.; Mourtzakis, M.; Hakimi, A. A.; Russo, P.; Jaimies, E.; Bradshaw, P.; more...
The Oncologist (2024)

Fulltext@MSK | Save

Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)

Meeting Abstract

Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma

Meeting Abstract

Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports

Meeting Abstract

Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study

Meeting Abstract

Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)

Meeting Abstract

Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study

Meeting Abstract

Agrawal, P.; Offin, M.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Off-label use of fam-trastuzumab deruxtecan-nxki with early activity in a cohort of patients with desmoplastic small round cell tumor

Meeting Abstract

Slotkin, E. K.; Burke, C.; Hameed, M.; Antonescu, C. R.; Agaram, N. P.; Bhanot, U.; Behr, G.; Price, A.; Pandit-Taskar, N.; Domenico, D.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma

Meeting Abstract

Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Jacobi, R.; Aggen, D. H.; McHugh, D. J.; Shah, N. J.; Carlo, M. I.; Keegan, N. M.; Gayadin, Y.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save